NYU
160 East 34th St.
New York, NY 10016

 

 

Certain cancers tend to spread to the lining of the abdominal cavity, a condition known as carcinomatosis or peritoneal surface malignancy. Until recently, treatment options could only provide relief from symptoms, with little hope of stopping the disease from recurring. Surgeons can now provide hope for people with peritoneal surface malignancies by combining surgery with a procedure known as Hyperthermic IntraPEritoneal Chemotherapy or HIPEC.

Every patient under consideration for HIPEC is thoroughly evaluated by the multidisciplinary team of the NYU Cancer Center.  Our group of Surgical Oncologists is supported by colleagues in Medical Oncology, Gastroenterology, and Radiology – all with specific expertise in intraperitoneal chemotherapy.  Each case is discussed in detail and imaging studies are reviewed at our weekly GI Oncology Conference. This integrated approach ensures the best care, both now and long-term, for all of our patients.

Schedule a conversation with a surgeon today!

HIPEC at NYU

HIPEC is an alternative and innovative method of delivering chemotherapy, which is commonly used to treat many types of cancer, to the body. Unlike traditional chemotherapy that is delivered intravenously, HIPEC delivers chemotherapy directly into the abdomen making it a good option for cancers that originated in or have spread to the abdominal cavity. How does HIPEC work? First, your surgeon removes any visible tumors from the abdomen. Next, HIPEC delivers heated chemotherapy directly inside the abdomen to help destroy any remaining cancer cells and very small tumors that cannot be seen by the surgeon. This is because the chemotherapy circulates inside the abdomen, allowing it to reach more places. The goal of HIPEC is to prevent these cells from growing into new tumors and causing

How does HIPEC work?

First, your surgeon removes any visible tumors from the abdomen. Next, HIPEC delivers heated chemotherapy directly inside the abdomen to help destroy any remaining cancer cells and very small tumors that cannot be seen by the surgeon. This is because the chemotherapy circulates inside the abdomen, allowing it to reach more places. The goal of HIPEC is to prevent these cells from growing into new tumors and causing First, your surgeon removes any visible tumors from the abdomen. Next, HIPEC delivers heated chemotherapy directly inside the abdomen to help destroy any remaining cancer cells and very small tumors that cannot be seen by the surgeon. This is because the chemotherapy circulates inside the abdomen, allowing it to reach more places. The goal of HIPEC is to prevent these cells from growing into new tumors and causing the cancer to return.

What are the benefits of HIPEC procedures?

  • HIPEC allows for a higher concentration of chemotherapy to be delivered into the abdomen more effectively and safer than standard chemotherapy, which is delivered intravenously.
  • This type of chemotherapy is best at killing cancer cells that are too small to be seen with the naked eye.
  • Chemotherapy delivered through HIPEC causes fewer side effects than intravenous chemotherapy. This is because the high concentrations of chemotherapy solution are unable to cross what is known as the peritoneal plasma barrier.
  • Experts say that pairing surgery and HIPEC together may be more beneficial than chemotherapy alone.

Am I a candidate for HIPEC?

Typical HIPEC patients are those with certain Stage IV abdominal cancers. Many are seeking an alternative to traditional chemotherapy or radiation therapy, as these options offer limited success treating advanced abdominal cancers. Patients also may have been told that no other treatment will work, but are still hoping to find a solution.

 

The Hospitals

The NYU Langone Medical Center, a world-class patient-centered integrated academic medical center, is one of the nation’s premier centers for excellence in healthcare, biomedical research, and medical education. HIPEC is offered at three of the NYU Langone Medical Center hospitals.

Tisch Hospital is a 700-bed institution that is the home of several innovative centers and programs. Tisch Hospital’s facilities include 66 operating rooms and a new 32-bed state-of-the art critical care unit.

Bellevue Medical Center is the nation’s oldest public hospital and is the flagship of the New York City public hospital system named the Health and Hospitals Corporation.  This 750-bed facility provides healthcare services to patients of all backgrounds.

The Manhattan Veteran’s Administration Hospital, a 170-bed facility, is part of the New York Harbor Healthcare System and provides healthcare services for New York City’s veteran population. The Manhattan campus is one of few VA hospitals that offer HIPEC and is proud to be a regional referral center.

HIPEC Research at NYULMC

Second Look Trial

Principal Investigator: Dr. Marcovalerio Melis

Certain patients are at high risk for carcinomatosis following curative treatment for colorectal cancer. Treatment of carcinomatosis is most effective when found early, however current imaging modalities such as CT scan, PET scan and MRI are limited in their ability to detect early peritoneal recurrence. Patients enrolled in this trial undergo planned diagnostic laparoscopy 9 months after completion of their treatment for the primary tumor in order to assess for early carcinomatosis.